BACKGROUND
Fatigue is frequently reported by patients with IBD, despite disease remission. However, few previous intervention trials have specifically assessed this symptom.
Main fatigue outcomes:
• Significant deterioration in FACIT-F score (more fatigue) (95%CI: -8.6 to (-0.7); p=0.02) with omega-3 fish oil • Significant reduction in fatigue in exercise groups, measured by IBD-F Section I score (95%CI: -3.8 to -0.2; p = 0.03)
CONCLUSIONS
The apparent worsening of fatigue with fish oil is unexplained. Exercise and fish oil, singly or in combination, were shown to be safe and generally well-tolerated in IBD patients. There was no evidence of adverse exercise-related effects on gut-related symptoms, and some evidence of improvement in fatigue. Hence, regular moderate-vigorous exercise may provide self-management options in IBD-related fatigue. 
AIM
To test the effects on fatigue in Inflammatory Bowel Disease (IBD) patients from:
• Individual advice to increase physical activity (PA) and/or • Supplementation with omega-3 fatty acids.
METHODS
Design: Randomised controlled 2x2 factorial pilot study comparing change-from-baseline scores in intervention and control groups. 
Intervention:
Control: Placebo supplement; diet diary. Exercise and placebo: Consultation (15 minutes) with personal trainer; activity and diet diary. Diet treatment: Fish oil supplement (2.97g per day omega-3, "Take Omega 3"©, Edinburgh, UK); diet diary. Diet and Exercise: Consultation with personal trainer (15 minutes); activity and diet diary. All patients received follow-up support (email, telephone).
Adverse events:
One treatment-related event (in exercise group); neither exercise nor fish oil were associated with likelihood of occurrence of adverse effects, including gastrointestinal symptoms.
• No significant interactions between effects of exercise and fish oil on fatigue • No consistent trends in fatigue or PA levels across the various measures between the four treatment groups Baseline: Similar parameters for gender, age, disease location, past IBD activity, level of PA, or FACIT-F.
